Axiron Topical Solution


Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XR

Perrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.

WWJ Newsradio 950–05/29/2013